Ocugen, Inc.
OCGN- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001372299
In the last 90 days, Ocugen, Inc. insiders filed 0 open-market purchases and 1 sale; 147 institutions reported holding it in 13F filings for Q2 2026, worth $222.1M in total; no superinvestor holds it.
13F holders, Q3 2025
Institutional positions in Ocugen, Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 97
- −6 vs. Q2 2025
- Shares held
- 45.9M
- −5.74M (−11.1%) vs. Q2 2025
- Total value
- $74.8M
- +$24.7M (+49.3%) vs. Q2 2025
- New holders
- 18
- 21 more added
- Sold out
- 24
- 35 more reduced
1 institution that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting OCGN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 147 | $222.1M |
| Q1 2026 | 137 | $200.5M |
| Q4 2025 | 109 | $82.2M |
| Q3 2025 | 97 | $74.8M |
| Q2 2025 | 104 | $50.1M |
| Q1 2025 | 110 | $54.2M |
| Q4 2024 | 114 | $57.7M |
| Q3 2024 | 115 | $79.1M |
| Q2 2024 | 101 | $104.4M |
| Q1 2024 | 81 | $54.0M |
| Q4 2023 | 68 | $15.1M |
| Q3 2023 | 78 | $13.2M |
| Q2 2023 | 96 | $26.5M |
| Q1 2023 | 103 | $53.2M |
| Q4 2022 | 114 | $117.0M |
| Q3 2022 | 128 | $146.5M |
| Q2 2022 | 124 | $193.1M |
| Q1 2022 | 122 | $279.2M |
| Q4 2021 | 122 | $291.2M |
| Q3 2021 | 116 | $396.4M |
| Q2 2021 | 129 | $455.7M |
| Q1 2021 | 82 | $167.3M |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding Ocugen, Inc.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Quantessence Capital LLC | 0 | $0 | 0.00% | −200,783−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −197,352−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −194,216−100.0% | Sold out |
| Catalyst Funds Management Pty Ltd | 0 | $0 | 0.00% | −134,000−100.0% | Sold out |
| Laurion Capital Management LP | 0 | $0 | 0.00% | −114,943−100.0% | Sold out |
| DRW Securities, LLC | 0 | $0 | 0.00% | −81,903−100.0% | Sold out |
| Gerber Kawasaki Wealth & Investment Management | 0 | $0 | 0.00% | −69,148−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −60,400−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −58,762−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −55,620−100.0% | Sold out |
| LPL Financial LLC | 0 | $0 | 0.00% | −53,990−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −30,824−100.0% | Sold out |
| AQR Capital Management LLC | 0 | $0 | 0.00% | −23,448−100.0% | Sold out |
| Mackenzie Financial Corp | 0 | $0 | 0.00% | −18,748−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −12,538−100.0% | Sold out |
| TCG Advisory Services, LLC | 0 | $0 | 0.00% | −11,964−100.0% | Sold out |
| Neuberger Berman Group LLC | 0 | $0 | 0.00% | −10,744−100.0% | Sold out |
| National Bank of Canada | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| True Wealth Design, LLC | 0 | $0 | 0.00% | −244−100.0% | Sold out |
| Bangor Savings Bank | 0 | $0 | 0.00% | −150−100.0% | Sold out |
| NBT Bank N A | 0 | $0 | 0.00% | −50−100.0% | Sold out |
| Iron Horse Wealth Management, LLC | – | – | – | – | Not filed |